 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Tilray, Inc. (TLRY) engages in the research, cultivation, production, marketing, and distribution of medical cannabis products.
The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development.
It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products.
The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.
The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Tilray reported a 1st Quarter August 2021 loss of $0.08 per share on revenue of $168.0 million on October 7th. The consensus estimate was a loss of $0.06 per share on revenue of $178.8 million.
After gaining momentum as the Bacardi executive, Blair MacNeil, was announced as the company's president to oversee the company's sales, marketing, and operations, this stock should continue to see an increase in share prices.
Entry Point: $10.75
Trading Range: $5.25 - $67.00
Stop Loss: $10.20
Target Price: $11.80
